Blood glucose and plasma insulin studies during three months' use of a low-estrogen type oral contraceptive.
Blood glucose and plasma insulin levels were measured during an oral glucose tolerance test in 18 women before and after 3 months' use of a low-estrogen oral contraceptive containing 0.035 mg of ethinylestradiol and 0.5 mg of norethindrone. There was no significant change in either of these two metabolic parameters. In addition, the blood pressures and weights of the women were unchanged during that time. Although these are only preliminary data, they are encouraging, for similar studies with higher-dose preparations often showed significant alterations in carbohydrate tolerance.
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007328:Insulin / Q000097:blood*; D009640:Norethindrone / Q000494:pharmacology*; D011446:Prospective Studies
D001786:Blood Glucose; D007328:Insulin; D004997:Ethinyl Estradiol; D009640:Norethindrone